PROPHETMELANOMA Trademark
Trademark Overview
On Tuesday, September 9, 2025, a trademark application was filed for PROPHETMELANOMA with the United States Patent and Trademark Office. The USPTO has given the PROPHETMELANOMA trademark a serial number of 79434418. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, November 5, 2025. This trademark is owned by ONCOHOST LTD. The PROPHETMELANOMA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical analysis services; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services for discovering new targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services to support treatment decisions in cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms.
General Information
| Serial Number | 79434418 |
| Word Mark | PROPHETMELANOMA |
| Filing Date | Tuesday, September 9, 2025 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Wednesday, November 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | PROPHET MELANOMA |
| Goods and Services | Medical analysis services; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services for discovering new targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services to support treatment decisions in cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms. |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 9, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ONCOHOST LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | IL |
Trademark Events
| Event Date | Event Description |
| Thursday, October 9, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, October 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 13, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 4, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, November 5, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, November 6, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
